Navid Sobhani

Scientist, Ph.D.


Curriculum vitae


[email protected]


Department of Cancer Biology

UT MD Anderson Cancer Center



Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion


Journal article


Navid Sobhani, Alberto D'Angelo, Matteo Pittacolo, Giuseppina Mondani, Daniele Generali
Cancers, vol. 16(17), 2024, p. 3089


Cite

Cite

APA   Click to copy
Sobhani, N., D'Angelo, A., Pittacolo, M., Mondani, G., & Generali, D. (2024). Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion. Cancers, 16(17), 3089. https://doi.org/10.3390/cancers16173089


Chicago/Turabian   Click to copy
Sobhani, Navid, Alberto D'Angelo, Matteo Pittacolo, Giuseppina Mondani, and Daniele Generali. “Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion.” Cancers 16, no. 17 (2024): 3089.


MLA   Click to copy
Sobhani, Navid, et al. “Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion.” Cancers, vol. 16, no. 17, 2024, p. 3089, doi:10.3390/cancers16173089.


BibTeX   Click to copy

@article{navid2024a,
  title = {Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion},
  year = {2024},
  issue = {17},
  journal = {Cancers},
  pages = {3089},
  volume = {16},
  doi = {10.3390/cancers16173089},
  author = {Sobhani, Navid and D'Angelo, Alberto and Pittacolo, Matteo and Mondani, Giuseppina and Generali, Daniele}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in